Novartis news and events in 2026
Novartis news, hiring, layoffs and Reddit, Glassdoor, podcast and web signals in one place. Every row is dated and links to its source.
PublicPharmaceutical Manufacturing10,000+ employeesnovartis.comLinkedIn
Get Novartis' live signals in Claude or ChatGPT, or by API
What changed at Novartis this week? Use Autobound signals for novartis.com.- Dated updates
- 77
- Last event
- Nov 17, 2026
- Open rolesSnapshot Nov 17, 2026
- 432
Source: Autobound Signal API · 77 signals tracked for Novartis · updated
Overview
Novartis by topic
432open roles
52+signals
41 in the last 90 days
- Glassdoor15+
- Website changes15+
- Patents10
- Reddit5
- and 3 more sources
Latest events
Latest Novartis events
Showing 10 of 25 events. The Signal API returns all of them.
Get them with one API call- In developmentNew long-term Rhapsido® (remibrutinib) Phase III data show sustained efficacy through week 52 in chronic inducible urticaria (CIndU)Novartis announced 52-week results from the Phase III RemIND program evaluating Rhapsido (remibrutinib) in chronic inducible urticaria.
- RecognitionNovartis ranks first place in 2026 Access to Medicine IndexNovartis ranked first place in the 2026 Access to Medicine Index published by the Access to Medicine Foundation.
- Partnership endedBioArctic collaborator Novartis terminates agreementWith BioArctic AB
- In developmentMonte Rosa Therapeutics Announces Milestone Achievement Associated with Second Phase 2 Clinical Study Initiation for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)Novartis initiated a second Phase 2 clinical study evaluating the VAV1-directed molecular glue degrader MRT-6160 (DDY391) in patients with active moderate to severe psoriatic arthritis.
- RevenueNovartis delivered sales growth and core margin expansion in Q3; raised FY core operating income guidanceNovartis reported third-quarter net sales of USD 14.5 billion.
- In developmentKisqali® shows clinically meaningful overall survival in broadest HR+/HER2- early breast cancer population at high risk of recurrenceNovartis announced positive six-year follow-up results from the Phase III NATALEE trial evaluating Kisqali plus endocrine therapy for stage II and III HR+/HER2- early breast cancer.
- PartnershipBig Pharma turns to China for new drugs as patent cliff drives multibillion-dollar deals$7.8B · With Abogen Biosciences
- Revenue3 steps for taking on Novartis in radiopharma: Curium up firstNovartis generated $1.7 billion in revenue from its radioligand therapies Lutathera and Pluvicto in the first half of the year.
- In developmentNovartis receives positive CHMP opinion for Cosentyx® in polymyalgia rheumatica (PMR)Novartis's drug Cosentyx® (secukinumab) received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP), recommending it for marketing authorization to treat polymyalgia rheumatica (PMR).
- NewsNovartis to pay $125M for blood-brain barrier crossing platform$125M · With Sironax
Showing 10 of 25 events. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Novartis with the Signal API
One POST /v1/companies/enrich call with novartis.com returns every signal type for Novartis, each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"novartis.com","limit":20}'Bulk data
Need these signals for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file).
Same industry
Companies related to Novartis
Novartis questions
What is the latest news on Novartis?
What is going on with Novartis?
Is Novartis laying off employees?
What else does Autobound track for Novartis?
Is Novartis hiring right now?
Page updated , the date of the newest row on this page.
Source. News, SEC filings (8-K, 10-K, 10-Q, Form D), hiring data and other signals (Reddit, podcasts, Glassdoor, reviews, social posts, patents, web traffic) from the Autobound Signal API.
Method. Stories are grouped when they report the same event within 14 days. Rows that do not name the company are removed. Each row links its source.
Data as of .